2. 2
OVERVIEW
1.
2.
3.
4.
Normal coagulation homeostasis
Classification of bleeding disorders
Clinical evaluation of bleeding disorders
Laboratory evaluation of bleeding disorders
a. Screening tests
SCREENING TESTS FOR PRIMARY HEMOSTASIS
1. Peripheral smear
2. Platelet count
3. Bleeding time
4. Platelet function analysis
SCREENING TESTS FOR SECONDARY HEMOSTASIS
1. Clotting time
2. Prothrombin time
3. Activated partial thromboplastin time
4. Thrombin time
Summary of screening tests
b. Specific tests
TESTS FOR PLATELET FUNCTIONS
1. tests for platelet adhesion
2. Test for platelet aggregation
3. Test for platelet release reaction
4. Test for clot retraction
5. Test for platelet procoagulant activity
6. Test for glycoproteins on platelet surface
7. Test for abnormalities in arachidonic acid metabolism
TESTS FOR COAGULATION FACTORS
1. coagulation factor assays
2. Quantitative estimation of fibrinogen
3. Thromboplastin generation test
4. Mixing test based on PT or aPTT
5. FXIII qualitative assay
6. Paracoagulation test
TESTS FOR FIBRINOLYSIS
1. Detection of fibrinogen and fibrin degradation products
2. Detection of cross linked fibrin D dimmers
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
3. 3
* NORMAL COAGULATION HOMEOSTASIS
1. Normal coagulation involves interaction of vessel walls, platelets and coagulation factors
2. Problems at any one of these steps may lead to abnormal homeostasis
Vessel injury
Collagen exposure
Platelet adhesion
FXII activatn
Vasoconst
Platelet release reaction
riction
5-ht
Tissue thrombo
plastin
BLOOD COAGULATION
TXA2
Platelet aggregation
Fibrinogen + thrombin
Primary hemostatic plug
Fibrin
Stabilized hemostatic plug
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
4. 4
* CLASSIFICATION OF BLEEDING DISORDERS
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
5. 5
* CLINICAL EVALUATION OF BLEEDING DISORDERS
History from the patient can tell whether the disorder is –
1. Localized or generalized
2. hereditary or acquired
3. Platelet disorder or coagulation disorder
Localized
1. Localized bleeding
Generalized
1. recurrent episodes of bleeding in response
to trivial trauma
2. bleeding from more than one site
3. spontaneous bleeding
4. excess bleeding following minor surgeries
like tooth extraction, tonsillectomy,
circumcision
Hereditary
onset early in life
similar disorder in close relatives
past history of similar episodes
history of disorder only in males on
the maternal side for many
generations – X linked Hemophilia A or
B
5. history of consanguineous marriage,
both males and females only from the
current generation affected –
Autosomal recessive disorders like
afibrinogenemia, von willebrand
disease, Factor V or Factor X deficiency
6. Bleeding in both males and females,
bleedin in one parent, bleeding in all
generations – Autosomal dominant
disorders like von willebrand disease,
hereditary hemorrhagic telengectasia
1.
2.
3.
4.
Sex affected
Family history
Petechiae, bleeding gums,
epistaxis, menorrhagia
Deep hematoma in muscle
and joints
Delayed bleeding from same
site (12-24 hrs after)
Previous history of bleeding
Acquired
usually secondary to disorders of
1. liver
2. uremia
3. hematologic malignancies
4. carcinoma
5. sepsis
Platelet disorders/
Vascular disorders
Female
Negative
Common
Coagulation
disorders
Male
Positive
Rare
Rare
Common
Rare
Common
Not present
Present since childhood
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
6. 6
* SCREENING TESTS FOR PRIMARY HEMOSTASIS
(i) Platelet count
1. MANUAL METHOD:
Blood + 1% Ammonium oxalate
counted on neubauer’s chamber
(small roughly spherical refractile particles)
Normals:
Platelet count
1,50,000 to 4,00,000 lakhs/mm3
2. AUTOMATED METHOD:
1. A cell counter analyses platelets based on its size.
2. Other platelet associated parameters like MPV, PDW and reticulated platelets are also
obtained
MPV (mean platelet volume)
In some platelet disorders, abnormally large platelets are released in circulation
MPV increased
1. myeloproliferative disorders
2. peripheral destruction of platelets
MPV normal
1. Thrombocytopenia due to impaired
platelet production like
thrombocytopenia
PDW (platelet distribution width)
Measure of degree of variation in platelet size
PDW increased
Myeloproliferative disorder
PDW normal
Secondary or reactive thrombocytosis
Reticulated platelets:
Concept analogous to reticulocytes.
Increased
Peripheral destruction
Normal
Aplastic anemia
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
7. 7
(ii) Peripheral Smear
For details on peripheral smear examination, refer to separate notes on the same. Only
salient points related to platelet examination will be described here.
Examination of platelets on peripheral smear helps to rule out falsely low counts on
automated methods, like due to clumping.
Total count
RBC
WBC
Platelet
Associated abnormalities in other cell lines
Fragmented RBCs indicate DIC with thrombocytopenia
Abnormal cells with thrombocytosis/thrombocytopenia (leukemias)
Normal count
1 platelet per 500-1000 red cells
Giant platelets
Myeloproliferative neoplasms
Bernard soulier syndrome
ITP
Discrete isolated platelets
Glanzmann’s thrombasthenia
without clumping in finger prick
Uremia
smear
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
8. 8
(iii) Bleeding time
Definition:
Time required for bleeding to cease following skin puncture/incision.
Methods:
1. Duke
a. lobe is punctured
b. method is not standardized
2. Ivy
a. On volar surface of forearm with lancet
b. Depth of 2 – 2.5 mm under standard venous pressure of 40 mm Hg
c. Blood oozing is blotted with filter paper
d. Time taken to stop bleeding is noted
3. Template
a. uses same site as Ivy
b. larger surgical blade is used for incision, depth 6-9 mm
Normals:
Ivy’s method
2 to 7 minutes
Causes of prolonged bleeding time:
See chart on page 4
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
9. 9
(iv) Platelet function analysis
Principle:
Blood aspirated through
Capillary into machine
collagen
epinephrine/
ADP
Blood passes through
Aperture in
Machine which is coated with
Platelet agonists such as
Collagen/epinephrine/ADP
The PFA 100 ANALYSER
Platelet adhesion, activation
And aggregation closes the
Aperture overtime
This time known as closure time is indicator of
Platelet function
Abnormals:
Closure time is prolonged in
1. Platelet disorders
2. Von willebrand disease
not prolonged in vascular disorders
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
10. 10
* SCREENING TESTS FOR SECONDARY HEMOSTASIS
(i) Clotting time
Definition:
Time required for whole blood to clot in a glass test tube at 37˚ C
Normals:
Clotting time
5-15 mins
Abnormals:
1. Prolonged in defects of common/intrinsic pathway$
2. But is less sensitive, prolonged only when factor levels drop to <1% of normal, time is
not prolonged in mild / moderate deficiency
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
11. 11
$ see next page for coagulation pathways details
Pathways of coagulation
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
12. 12
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
13. 13
(ii) Prothrombin time (PT) and Activated partial thromboplastin time
(aPTT)
Precautions and prerequisites:
1. Venepuncture the anticubital vein, with minimal trauma to avoid tissue thromboplastin
release
2. Donot collect from indwelling catheters to avoid mixing with tissue fluids
3. Use plastic syringes with 20-21 G needles. Donot use glass syringes/bottles as glass
activates contact factors and initiates clotting through intrinsic pathway.
4. Prolonged tourniquet should be avoided as it causes increased fibrinolysis
5. Anticoagulant used in sodium citrate (3.2%) as it causes rapid chelation of calcium & FV
and FVIII remain relatively more stable in it, blood:anticoagulant ratio = 1:9
6. Allow blood to flow gently down the sides of tube/container
7. thoroughly mix blood and anticoagulant
8. transport the tightly sealed tube to lab without delay
9. if labile coagulation factors are to be measured, maintain tube at 4˚C
10. Coagulation studies should be carried out within 2 hours of collection
PROTHROMBIN TIME:
Method:
1. Prepare platelet poor plasma (PPP)
Allow blood in citrate tube to stand
centrifuge at 3000-4000 rpm for 15/20 min
Platelets, RBC and WBC will settle down
Use supernatant
(for platelet function studies, we need to use platelet rich plasma)
2. Take 25 µl PPP in a cuvette A. Take 25 µl tissue thromboplastin + 25 µl calcium chloride
in another cuvette B.
3. Place PPP cuvette in reader
4. Start optic reader
5. Put contents of cuvette B (total 50 µl) into cuvette A
6. Obtain readings of PT and INR
7. A control sample must be run along with patient’s
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
14. 14
Principle:
1. Tissue thromboplatin activates factor VII and initiates the extrinsic pathway of
coagulation
2. Thromboplastin also provides phospholipids for certain coagulation reactions
3. PT measures activity of Extrinsic
and
common pathways
FVII
F X, V, II, I
CONCEPT OF INR
1. The international normalized ratio (INR) was introduced in an attempt to standardize
the PT.
2. In its original manifestation, the PT was very variable because different thromboplastins
were non-standardized and derived from many varied sources. PTs performed on the
identical specimen by different laboratories were inconsistent.
3. The concept behind the INR is that differences between the thromboplastins are
accounted for by a calculation:INR = [PT (patient) ÷ PT (Control)]ISI
The INR has no units (it is a ratio) and is determined to one decimal place.
ISI, or international sensitivity index is a function of the thromboplastin reagent.
Normals:
PT
INR
11-16 Seconds
0.9 – 1.1
Abnormals:
PT is prolonged in
1. Vitamin K deficiency – (F II, VII, IX, and X are vit K dependent factors out of which F VII
and X are important in extrinsic and common pathways) Extrinsic and common
pathways are affected
2. Oral anticoagulant therapy – PT is standard for monitoring anticoagulant therapy
Recommended Therapeutic Range for Oral Anticoagulant Therapy.
INDICATION
INTERNATIONAL NORMALIZED RATIO (INR)
Treatment of venous thrombosis
Treatment of pulmonary embolism
Prevention of systemic embolism
Tissue heart valves
Acute myocardial infarction
Atrial fibrillation
2.0 - 3.0
Recurrent embolism
Mechanical heart valve
Antiphospholipid antibodies
2.5 - 3.5
3. DIC – exhaustion of coagulation factors
4. Inherited deficiency of coagulation factors
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
15. 15
ACTIVATED PARTIAL THROMBOPLASTIN TIME:
Method:
1. Prepare platelet poor plasma as above
2. Take 25 µl sample in cuvette, add 25 µl aPTT reagent (which contains activator#) to it
3. Incubate for 180 secs
4. Place cuvette in optic area
5. Add 25 µl calcium chloride when ready
6. A control should always be run along with the patient’s
#
Activator is not present in PT reagent, activators used can be kaolin, elite, ellagic acid, silica etc.
Normals:
aPTT
30-40 seconds
Principle:
1. The activator activates intrinsic pathway of coagulation.
2. Thus PT is altered in intrinsic and common pathway defects.
Abnormals:
aPTT is prolonged in:
1. Inherited deficiencies of factor VIII (Hemophilia A) and Factor IX (Hemophilia B)
2. Non specific inhibitor antibodies against F VIII e.g. Lupus inhibitor
a. Donot act directly but block interaction of FVIII with other clotting factors
3. DIC
4. Heparin
a. Inhibits factor XII, XI and X through antithrombin III
b. Heparin therapy is monitored through aPTT
5. Vit K deficiency
Affects Factor IX
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
16. 16
(iii) Thrombin Time (TT)
It is a test for plasma fibrinogen levels.
Method:
1. Platelet poor plasma + thrombin reagent
2. Time required for clotting is noted
Principle:
1. Plasma fibrinogen is cleaved by thrombin (activated factor II) to form fibrin clot
Normals:
TT
11.6 – 20.7 seconds
Abnormals:
TT is prolonged in
1. Afibrinogenemia (<100 mg/dl) or dysfibrinogenemia
2. Fibrinogen or fibrin degradation products (interfering substances)
3. presence of heparin in plasma
4. chronic liver disease
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
17. 17
*SUMMARY OF SCREENING TESTS
DEFECT IN
BT
Thrombocytopenia
Extrinsic pathway
Intrinsic pathway
N
N
N
N
Common pathway
N
PT
APTT
N
N
N
Platelet fuction/
vascular disorders/ vW
defects
PLATELET
COUNT
N
N
N
Multiple pathways (DIC)
Clot stabilization
N
N
N/
N
N
N
N
COMMON CAUSES
Von willebrand disease
Storage pool defects
Other platelet affecting
disorders
All causes of
thrombocytopenia
See causes of prolonged PT
See causes of prolonged
aPTT
Causes of either prolonged
PT or prolonged aPTT
DIC/Liver disease
FXIII deficiency
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
18. 18
*TESTS FOR PLATELET FUNCTION
(i) Test for platelet adhesion (Glass bead column test)
Blood
Platelets counted before entering glass column
Glass column with beads, adhesion of platelets
Occurs here
Aggregation also occurs, hence is non specific
Platelets are counted after passing through
Glass column
Normals:
>25 % retention of platelets
Normal
Abnormals:
1. <25% retention is observed with von willebrand’s disease
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
19. 19
(ii) Test for platelet aggregation
Method:
Prepare platelet rich plasma
Add aggregating agent and put in aggregometer
As platelets aggregate, more light passes through
Two waves are obtained on graph from the machine, primary wave and secondary wave
(biphasic) corresponding to degree of platelet aggregation against time
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
20. 20
Aggregating agents used
ADP / Epinephrine
Curve type
Biphasic
Collagen / ristocetin / Arachidonic acid
Monophasic curve
Normals:
Bi phasic ADP curves
Biphasic epineph
Monophasic collagen
Monophasic ristocetin
monophasic AA
See control lines in the graphs
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
21. 21
Abnormals:
1. GLANZMANN’S THROMBASTHENIA
1.
2.
3.
4.
In Glanzmann’s thrombasthenia, Platelet GPIIb/IIIa is defective.
This receptor is important for platelet aggregation.
All agents induce aggregation through this receptor except ristocetin.
Hence in Glanzmann’s thrombasthenia, aggregation is defective for all agents except
ristocetin.
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
22. 22
2. BERNARD SOULIER SYNDROME AND VON WILLEBRAND DISEASE
1. In Bernard soulier syndrome there is deficiency of GpIb/IXa, whereas in von willebrand
disease, there is deficiency of von willebrand factor.
2. Aggregation is there in response to all agents except ristocetin
BS and VWD can be differentiated by addition of normal plasma. If the aggregation is seen
now, it means the disease is VWF because normal plasma is a source of VWF.
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
23. 23
3. STORAGE POOL DEFECTS
1. In this disorder, there is defective granule release from platelets
2. Due to defective release reaction, secondary aggregation is defective
3. Hence there is no secondary wave in response to ADP/epinephrine/collagen and only
partial aggregation in response to ristocetin.
4. ASPIRIN LIKE DEFECT (DEFECT IN COX PATHWAY)
1. Absent aggregation to arachadonic acid.
2. Primary wave aggregation only with ADP.
3. Decreased or absent aggregation with collagen
Disorder
Aggregating agents
ADP/EPINEPHRINE/COLLAGEN
PRIMARY WAVE
SECONDARY WAVE
BS syndrome
N
N
vWD
N
N
Glanzmann’s
D
D
Storage pool$
N
D
$
Aspirin like
D
D
Aspirin like in
N
D
response to AA$
(AA used)
(AA used)
N normal D deficient AA arachidonic acid
$
Measure of platelet release reaction
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
RISTOCETIN
D
D
N
N
D
D
24. 24
(iii) Tests for platelet release reaction
Indirect Tests
Direct Tests
The secondary wave of aggregation in
Response to ADP/epinephrine/collagen
is a measure of release reaction
1. estimation of secretion of
dense core granules
2. estimation of secretion of
alpha granules
Dense core granules
Alpha granules
Contents of platelet granules
adenosine diphosphate (ADP)
adenosine triphosphate (ATP)
ionized calcium (which is necessary for several steps of the
coagulation cascade)
histamine
serotonin
insulin-like growth factor 1
platelet-derived growth factor
TGFβ
platelet factor 4 (which is a heparin-binding chemokine)
other clotting proteins (such as thrombospondin, fibronectin,
and von Willebrand factor)
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
25. 25
Abnormals:
1. Storage pool deficiency
2. Aspirin like defect (COX deficiency)
(iv) Tests for clot retraction
1. Clot retraction is the "shrinking" of a blood clot over a number of days. In so doing, the
edges of the blood vessel wall at the point of injury are slowly brought together again to
repair the damage.
2. Clot retraction is dependent on release of multiple coagulation factors from platelets
trapped in the fibrin mesh of the clot. Thus, failure to retract can be a sign of
thrombocytopenia or Glanzmann’s thrombasthenia.
(v) Tests for platelet procoagulant activity
This test measures amount of residual prothrombin activity after whole blood is allowed to
clot completely.
Whole blood
In plain tube
allowed to clot
Citrated plasma
(same pt)
serum with residual
prothrombin
Perform PT
(PT1)
Perform PT
(PT2)
PT1
= PLATELET PROCOAGULANT ACTIVITY
PT2
Interpretation:
Presence of residual prothrombin (PCA >1) may be due to deficiency of coagulation factors
or of platelet phospholipids.
(vi) Tests for detection of glycoproteins on platelet surface (Flow
cytometry)
GpIb/IXa
Defective in Bernard soulier syndrome
GpIIb/IIIa
Defective in Glanzmann’s thrombasthenia
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
26. 26
(vii) Tests for defects in Arachidonic acid metabolism (AA)
1. Arachidonic acid is necessary for TXA2 generation which activates platelets.
2. Normal aggregation in response to Arachidonic acid shows defects in arachidonic acid
metabolism pathway
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
27. 27
*TESTS FOR COAGULATION FACTORS
(i) Coagulation factor assays
Principle:
Patient’s plasma
+
standard plasma deficient in
Factor to be tested in various
Dilutions
perform PT
and aPTT
Normal
Prolonged
Patients plasma
Contains that
Factor
patients plasma
doesn’t contain
that factor
Normals:
All factors
50-150 % or 50-150 U/dl
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
28. 28
(ii) Quantitative estimation of fibrinogen
Normals:
Fibrinogen levels
200-400 mg/dl
Abnormals:
Decreased fibrinogen
Increased fibrinogen
Afibrinogenemia, dysfibrinogenemia, DIC
MI, trauma, neoplasia, inflammatory conditions
Methods:
1. Coagulable protein method (based on thrombin time)
thrombin
Fibrinogen
fibrin
Thrombin time
thrombin time
α
1
concentration of fibrinogen
It means there is a linear relationship between concentration of fibrinogen and
thrombin time.
By comparing thrombin time of the test sample with thrombin time of known
fibrinogen standard in the same system, the concentration of sample can be
obtained by using a standard graph.
2.
3.
4.
5.
Immunological method (RIA based)
Heat precipitation test
Chemical precipitation test
Weighing of clot
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
29. 29
(iii) Thromboplastin generation test (TGT)
Method:
STAGE I
Sample
+
Phospholipid
+
Calcium
FXa-V complex
(aka prothrombinase) Generation of
Prothrombinase
Prothrombin
thrombin
Fibrinogen
Fibrin
estimation of clotting time
STAGE II
if clotting time is abnormal, PT and aPTT are done and substitutions studies are carried out
to determine deficient factors in plasma and serum.
Prepared Serum$
+
Sample
+
Phospholipids
+
calcium
Adsorbed plasma$$
+
Sample
+
Phospholipids
+
Calcium
estimation of clotting
time
estimation of clotting
time
$
prepared serum contains FV and VIII
adsorbed plasma – FIX and X
Both contain – FXI and XII
$$
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
30. 30
Ad Plasma substitution defective
Serum substitution defective
Both substitution defective
F V / VIII abnormal
F IX/X abnormal
F XI/XII abnormal
PT tests – F V, X
aPTT tests – F VIII,IX, XI, XII
Result interpretation:
History
Bleeding
Bleeding
Bleeding
Bleeding
Bleeding
No bleeding
Coagulation screen
PT
aPTT
N
P
P
N
N
P
P
N
N
P
N
P
TGT
Plasma defect
Plasma defect
Serum defect
Serum defect
Both defect
Both defect
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
Interpretation
F VIII deficient
F V deficient
F IX deficient
F X deficient
FXI deficient
F XII deficient
31. 31
(iv) Mixing test based on PT/aPTT
Done to differentiate clotting factor deficiency from prolonged PT/aPTT due to inhibitors
Method:
Prolonged PT or aPTT in patient suspected of bleeding disorder
Repeat PT/aPTT after adding normal plasma (patient plasma 50% + normal plasma 50%)
PT/aPTT normal
PT/aPTT still prolonged
Incubate at 37 deg and repeat
Due to immediate acting inhibitor
PT/aPTT prolonged
PT/aPTT still normal
Delayed acting
Inhibitor
coagulation factor deficiency
perform TGT
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
32. 32
(v) FXIII Qualitative assay (Urea clot lysis test)
Done when all other tests for hemostasis are normal.
FXIII provides stability to clot formed.
Method:
Fibrin
Fibrin clot
+5M urea
dissolves Unstable clot
FXIII def
Doesnot dissolve
FXIII
Normal
FXIII
(vi) Paracoagulation tests (protamine sulphate test & ethanol gelation
test)
Tests done to detect ongoing intravascular coagulation.
Rationale:
In circumstances such as after a major surgical procedure or liver disease
We need to know whether active coagulation is going on in plasma
This would be indicated by presence of soluble (non polymerized) fibrin monomers in
plasma
Method:
Platelet poor plasma + protamine sulphate/
Ethanol
gel formed – fibrin
monomer +nt
(active coagulation +nt)
No gel formed – fibrin
Monomer absent
(active coagulation –nt)
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes
33. 33
*TESTS FOR FIBRINOLYSIS
These are latex agglutination tests for
Fibrinogen and Fibrinogen degradation
Products (FDPs)#
D-dimers#
#Actual clot degradation process
plasmin
Fibrinogen
fibrinogen degradation
products
Thrombin
Fibrin polymer
FXIII
Cross linked fibrin
Plasmin
D dimer
Application:
1. for detecting DIC – (d dimer more specific)
2. pulmonary embolism
3. DVT
4. severe pneumonia
5. MI
Notes on Laboratory approach to bleeding disorders…by Dr. Ashish V. Jawarkar
Contact: pathologybasics@gmail.com Website: pathologybasics.wix.com/notes